A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dopamine hydrochloride | Dopamine hydrochloride (ASL279) is a catecholamine neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dopamine hydrochloride (ASL279) plays several important roles in the brain and body [1]. Dopamine hydrochloride (ASL279) acts through D2 dopamine receptor s to induce endocytosis of VEGFR2, which is critical for promoting angiogenesis [1]. Uses: Scientific research. Group: Natural products. Alternative Names: ASL279. CAS No. 62-31-7. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg; 500 mg. Product ID: HY-B0451A. |  |
| Dopamine Hydrochloride | Endogenous catecholamine with α and β-adrenergic activity. Cardiotonic; antihypotensive. Group: Biochemicals. Alternative Names: 4-(2-Aminoethyl)-1,2-benzenediol Hydrochloride; 4- (2-Aminoethyl) pyrocatechol Hydrochloride. Grades: Highly Purified. CAS No. 62-31-7. Pack Sizes: 1g. US Biological Life Sciences. |  Worldwide |
| Dopamine Impurity 15 | Dopamine Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-4-(2-nitrovinyl)benzene-1,2-diol. CAS No. 108074-44-8. Molecular formula: C8H7NO4. Mole weight: 181.15. Catalog: APB108074448. |  |
| Dopamine Impurity 20 | Dopamine Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: dibenzylamine. CAS No. 103-49-1. Molecular formula: C14H15N. Mole weight: 197.28. Catalog: APB103491. | |
| Dopamine Impurity 37 | Dopamine Impurity 37. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-2-(3,4-dimethoxyphenyl)-N-(4-(4-methoxyphenyl)butan-2-ylidene)ethanamine. CAS No. 1010809-74-1. Molecular formula: C21H27NO3. Mole weight: 341.44. Catalog: APB1010809741. | |
| Dopamine Impurity 5 | Dopamine Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1126-62-1. Molecular formula: C8H7NO2. Mole weight: 149.15. Catalog: APB1126621. | |
| Dopamine Impurity 76 | Dopamine Impurity 76. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13335-51-8. Molecular formula: C10H14O3. Mole weight: 182.22. Catalog: APB13335518. | |
| Dopamine Impurity 9 | Dopamine Impurity 9. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4-(2-aminoethyl)phenyl)(phenyl)methanone. CAS No. 101089-44-5. Molecular formula: C15H15NO. Mole weight: 225.29. Catalog: APB101089445. | |
| Dopamine Impurity 9 | Dopamine Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 102-32-9. Molecular formula: C8H8O4. Mole weight: 168.15. Catalog: APB102329. | |
| Dopamine Impurity C (3,4-Dimethoxyphenethylamine) | A methylated metabolite of Dopamine. Synonyms: 2-(3,4-Dimethoxyphenyl)-1-aminoethane; 2-(3,4-Dimethoxyphenyl)ethanamine; 2-(3,4-Dimethoxyphenyl)ethylamine; 3,4-Di-O-methyldopamine; 3,4-Dimethoxy-β-phenylethylamine. Grade: > 95%. CAS No. 120-20-7. Molecular formula: C10H15NO2. Mole weight: 181.24. |  |
| Dopamine Receptor Antagonist II, Thioridazine, HCl - CAS 130-61-0 | The Dopamine Receptor Antagonist II, Thioridazine, HCl, also referenced under CAS 130-61-0, controls the biological activity of Dopamine Receptor. This small molecule/inhibitor is primarily used for Biochemicals applications. Group: Fluorescence/luminescence spectroscopy. | |
| Dopamine Receptor D2 Control Peptide (DRD2) | Dopamine Receptor D2 Control Peptide (DRD2). Group: Molecular Biology. Grades: Purified. Pack Sizes: 150nmole. US Biological Life Sciences. | Worldwide |
| Dopamine-[ring-13C6] Hydrochloride | Dopamine-[ring-13C6] Hydrochloride. Synonyms: dopamine HCl ring-13C6; 2-(3,4-dihydroxyphenyl)-ethylamine HCl ring-13C6. Grade: 98% by CP; 99% atom 13C. CAS No. 335080-94-9. Molecular formula: C2[13C]6H12ClNO2. Mole weight: 195.60. | |
| Dopastin | It is produced by the strain of Pseudomonas sp. It has the effect of lowering blood pressure and inhibiting barley germination. Synonyms: NSC252927; N-(2(S)-Nitrosohydroxylamino-3-methylbutyl)crotonamide; (S-(E))-N-(2-(Hydroxynitrosoamino)-3-methylbutyl)-2-butenamide. Grade: 95%. CAS No. 37134-80-8. Molecular formula: C9H17N3O3. Mole weight: 215.25. | |
| DOPC | DOPC (1,2-Dioleoyl-sn-glycero-3-phosphocholine) is a high purity phospholipid utilized for liposome production. Uses: Dopc has been used for the reconstitution of proteoliposome (pl), used in the preparation of lipid vesicles. Synonyms: 1,2-Dioleoyl-sn-glycero-3-PC; 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; sn-3-Dioleoyllecithin; 1,2-DOPC; PDD 111; 18:1 PC. Grade: > 97.0% (T) (HPLC). CAS No. 4235-95-4. Molecular formula: C44H84NO8P. Mole weight: 786.11. | |
| DOPC:DOPE:Chol (50:30:20)-ATP Liposome | This product is a nuetral charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| DOPE | DOPE is a ph-sensitive neutral phospholipid that facilitates transmembrane transport of DNA-liposome complexes. Alternative Names: 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine; 3-SN-PHOSPHATIDYLETHANOLAMINE, 1,2-DIDEOYL;1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE. CAS No. 4004-05-1. Product ID: PIPB-0080. Molecular formula: C41H78NO8P. Mole weight: 744.05. SMILES: CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC. Appearance: Lyophilized powder. Category: LNP Raw Materials. |  |
| DOPE | DOPE (Dioleoylphosphatidylethanolamine) is a neutral helper lipid for cationic liposome and combines with cationic phospholipids to improve transfection efficiency of naked siRNA [1]. Uses: Scientific research. Group: Biochemical assay reagents. Alternative Names: Dioleoylphosphatidylethanolamine; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine. CAS No. 4004-5-1. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-112005. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Alcohols(DTO), 20wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Alcohols(DTO), 20wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. |  |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Alcohols(DTO), 40wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Alcohols(DTO), 40wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 20wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 20wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 40wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Aromatic(DTO), 40wt%. Uses: Screen technology, electronics, solar, heat and em shielding, conductive coatings. Group: Doped nanoparticles. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 20wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 20wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 40wt% | Doped Tin Oxide Nanoparticles/Nanopowder Dispersion in Water(DTO), 40wt%. Uses: Heat and ir shielding, antistatic, solar, displays, conductors. Group: Doped nanoparticles. | |
| Dopentacontane | Dopentacontane. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DOPENTACONTANE;ALKANE C52;N-DOPENTACONTANE;DOPENTACONTANE, STANDARD FOR GC. Product Category: Heterocyclic Organic Compound. CAS No. 7719-79-1. Molecular formula: C52H106. Mole weight: 731.4. Product ID: ACM7719791. Alfa Chemistry ISO 9001:2015 Certified. |  |
| DOPE-PEG-Biotin | DOPE-PEG-Biotin is a heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and a biotin. It can be used in targeted drug delivery with the lipid bilayer. Synonyms: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(polyethylene glycol)-Biotin. | |
| Dopexamine | Dopexamine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DOPEXAMINE;4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol;Dopacard;FPL-60278;FPL-60278AR;4-[2-[[6-(Phenethylamino)hexyl]amino]ethyl]-1,2-benzenediol;1,2-Benzenediol, 4-(2-((6-((2-phenylethyl)amino)hexyl)amino)ethyl)-;86484-91-5 (Di-hyd. Product Category: Heterocyclic Organic Compound. CAS No. 86197-47-9. Molecular formula: C22H32N2O2. Mole weight: 356.507. Product ID: ACM86197479. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dopexamine | Dopexamine is a synthetic dopamine analog and acts as a β2-adrenergic receptor agonist as well as an agonist at peripheral dopamine receptors. It has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Uses: Adrenergic beta-agonists. Synonyms: 1,2-Benzenediol, 4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]-; 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol; FPL 60278; 4-(2-((6-(Phenethylamino)hexyl)amino)ethyl)pyrocatechol. Grade: 95%. CAS No. 86197-47-9. Molecular formula: C22H32N2O2. Mole weight: 356.50. | |
| Dopexamine hydrochloride | Dopexamine is a synthetic dopamine analog and acts as a β2-adrenergic receptor agonist as well as an agonist at peripheral dopamine receptors. It has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Synonyms: 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol Dihydrochloride; Dopacard; Dopexamine Dihydrochloride; FPL 60278AR. Grade: 95%. CAS No. 86484-91-5. Molecular formula: C22H34Cl2N2O2. Mole weight: 429.43. | |
| Dopexamine hydrochloride | Dopexamine hydrochloride is a β2 adrenergic receptor agonist. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FPL60278AR. CAS No. 86484-91-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-U00205. | |
| Dopexamine Hydrochloride | Dopexamine is a synthetic dopamine analog and acts as a a β2-adrenergic receptor agonistt as well as an agonist at peripheral dopamine receptors. Dopexamine has been used to improve myocardial and renal performance in patients suffering from low cardiac output states. Group: Biochemicals. Alternative Names: 4- [2- [ [6- [ (2-Phenylethyl) amino] hexyl] amino] ethyl] -1, 2-benzenediol Dihydrochloride; Dopacard; Dopexamine Dihydrochloride; FPL 60278AR. Grades: Highly Purified. CAS No. 86484-91-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| DOPG | DOPG is a phosphatidylglycerol in which the phosphatidyl acyl groups are both oleoyl. It has been used to physically stabilize emulsions and suspensions. It is also used in formulations of pulmonary surfactants, intravenous fat emulsions, and oral solutions. Synonyms: Dioleoyl phosphatidylglycerol; 1,2-Dioctadecenoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; C18:1 phosphatidylglycerol; C18:1 PG; DOPG; 3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-[(9Z)-octadec-9-enoyloxy]propyl (9Z)-octadec-9-enoate. Grade: ≥95% by HPLC. CAS No. 62700-69-0. Molecular formula: C42H79O10P. Mole weight: 775.04. | |
| DOPG:Chol (70:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:Chol:PEG2000 (65:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (0.5:69.5:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (10:60:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (1:69:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (20:50:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (2.5:67.5:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol 30:40:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (40:30:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (50:20:30)ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (5:65:30 )-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol (60:10:30)-ATP Liposome | This product is a negatively charged ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (10:55:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (1:64:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (20:45:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (2.5:62.5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (30:35:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (40:25:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (50:15:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (5:60:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG:DOPC:Chol:PEG2000 (60:5:30:5)-ATP Liposome (PEGylated) | This product is a negatively charged PEGylated ATP liposome. Adenosine triphosphate (ATP) is the direct energy source required for all cellular life activities. Encapsulating it within liposomes prevents enzymatic hydrolysis, prolongs circulation time, and significantly enhances its therapeutic efficacy. Due to the instability of ATP, this product is in the form of lyophilized powder. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. | |
| DOPG sodium | DOPG sodium is a naturally occurring anionic phospholipid, containing oleic acid (18:1) inserted at the sn-1 and sn-2 positions. DOPG can form a lipid bilayer in an aqueous solution and is used in the generation of micelles, liposomes, and other artificial membranes. DOPG also exhibits anti-inflammatory properties [1]. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 67254-28-8. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-141571. | |
| D-O-Phospho threonine | D-O-Phospho threonine. Group: Biochemicals. Alternative Names: D-Threonine dihydrogen phosphate(ester); D-O-Phosphothreonine. Grades: Highly Purified. CAS No. 96193-69-0. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C4H10NO6P. US Biological Life Sciences. | Worldwide |
| Dopropidil | Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properties. Synonyms: 1-[1-(2-methylpropoxy)-3-(1-prop-1-ynylcyclohexyl)oxypropan-2-yl]pyrrolidine; 1-(1-((2-methylpropoxy)methyl)-2-((1-(1-propynyl)cyclohexyl)oxy)ethyl)pyrrolidine; 4205CERM; 4205CERM hydrochloride; CERM 4205; CERM4205; CERM-4205. CAS No. 79700-61-1. Molecular formula: C20H35NO2. Mole weight: 321.5. | |
| DOPS | DOPS (1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium salt) is high purity phospholipid utilized for liposome production. Synonyms: (2S,8R,19Z)-2-amino-5-hydroxy-11-oxo-8-[[(9Z)-1-oxo-9-octadecenyl]oxy]-4,6,10-trioxa-5-phosphaoctacos-19-enoic acid, 5-oxide, monosodium salt; L-α-Phosphatidyl-L-serine, dioleoyl sodium salt; 1,2-Dioleoyl-sn-Glycero-3-Phosphatidylserine Na salt; 18:1 PS. Grade: >98%. CAS No. 90693-88-2. Molecular formula: C42H77NO10P; Na. Mole weight: 810.03. | |
| DORA-22 | DORA-22 is a dual orexin receptor antagonist. It can improve mild stress-induced insomnia with minimal effect on memory. Synonyms: DORA22; DORA 22; (5-Fluoro-2-(pyrimidin-2-yl)phenyl)((2R,5R)-5-(((5-fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)methanone. CAS No. 1088991-95-0. Molecular formula: C23H22F2N4O2. Mole weight: 424.44. | |
| Doramapimod | Doramapimod (BIRB 796) is a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB-796 has entered clinical trials for the treatment of autoimmune diseases. Synonyms: Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-; N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea; Birb 796; BIRB 796BS; BRB 796; UNC 10225354; UNC10225354; 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea. Grade: >98%. CAS No. 285983-48-4. Molecular formula: C31H37N5O3. Mole weight: 527.66. | |
| Doramapimod | Doramapimod is a highly potent inhibitor of p38 mitogen-activated protein kinase (MAPK). Doramapimod is a potential agent for the treatment of inflammatory diseases. Doramapimod blocks baseline and bortezomib-triggered upregulation of p38 MAPK and Hsp27 phosphorylation leading to enhanced cytotoxicity and caspase activation. Group: Biochemicals. Alternative Names: N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea; BIRB 796BS; Birb 796. Grades: Highly Purified. CAS No. 285983-48-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Doramapimod | Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38?=38 nM, for p38?=65 nM, for p38?=200 nM, and for p38?=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BIRB 796. CAS No. 285983-48-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10320. | |
| Doramapimod (1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea, BRRB 796) | Cell-permeable. A potent protein kinase inhibitor with a >330-fold selectivity for p38 MAPK compared with 12 other protein kinases. In contrast to other p38 MAPK inhibitors, doramapimod prevents both the kinetic activity and phosphorylation of p38 MAPK by binding to the ATP pocket as well as to a novel allosteric binding site on p38 MAPK. Group: Biochemicals. Grades: Highly Purified. CAS No. 285983-48-4. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Doramectin | Doramectin is a veterinary drug approved by the Food and Drug Administration for the treatment of parasites such as gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites in cattle. Alternative Names: Doramectina. Doramectine. Doramectinum. CAS No. 117704-25-3. Product ID: API117704253. Molecular formula: C50H74O14. Mole weight: 899.1. EINECS: 601-490-4. SMILES: C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C8CCCCC8)C)O. Appearance: White to Off-white Solid. Category: Antiparasitic APIs. | |
| Doramectin | Doramectin is a derivative of ivermectin, which is an anthelmintic. Doramectin is an antiparasitic antibiotic produced by Streptomyces. Synonyms: UK67994. Grade: 95%. CAS No. 117704-25-3. Molecular formula: C50H74O14. Mole weight: 899.11. | |
| Doramectin | Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model [1] [2] [3]. Uses: Scientific research. Group: Natural products. CAS No. 117704-25-3. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-17035. | |
| Doramectin | Doramectin is a biosynthetic avermectin derived from a mutant of the original Streptomyces avermitilis strain supplemented with a cyclohexylcaboxylic acid starting unit. Doramectin was developed as an anthelmintic for internal parasite control. The presence of the cyclohexyl group replacing the sec-butyl moiety affords greater hydrophobicity and longer biological half-life compared to avermectin. Like the other milbemycin / avermectins, it selectively binds to parasite glutamate-gated chloride ion channels and disrupts neurotransmission leading to paralysis and death of the parasite. Group: Biochemicals. Grades: Highly Purified. CAS No. 117704-25-3. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Doramectin | Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 25-CYCLOHEXYL-5-O-DEMETHYL-25-DE(1-METHYLPROPYL)AVERMECTIN;DORAMECTIN;Doramectin VETRANAL;Doromectin;_x00B_25-Cclohexyl-avermectin B1;25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin A1A;Dectoma;UK-67994. Product Category: Inhibitors. Appearance: Solid. CAS No. 117704-25-3. Molecular formula: C50H74O14. Mole weight: 899.11. Purity: 0.9896. Canonical SMILES: CO[C@@H]1[C@@H](O[C@]2([H])O[C@@H](C)[C@H](O)[C@@H](OC)C2)[C@H](C)O[C@@]([H])(O[C@H](/C(C)=C/C[C@]3([H])C[C@]([H])(OC4=O)C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O3)[C@@H](C)/C=C/C=C7CO[C@@]8([H])[C@]\7(O)[C@@]4([H])C=C(C)[C@H]8O)C1. Product ID: ACM117704253. Alfa Chemistry ISO 9001:2015 Certified. | |
| Doramectin | analytical standard. Group: Pesticides & metabolites standardspesticides & metabolitespharma & vet compounds & metabolitesstable isotope labelled compoundsstandards for environmental regulatory methodspharma & vet compounds & metabolitesapi standardspharmaceutical toxicology. Alternative Names: 25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-avermectin A1a, 25-Cyclohexylavermectin B1, 25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin a1a, L 701023, Dectomax, Doramectin, Doramectin A1a, Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], avermectin A1a deriv., UK 67994. | |
| Doramectin | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C50H74O14. CAS No. 117704-25-3. Prepack ID 48672805-1g. Molecular Weight 899.11. See USA prepack pricing. |  |
| Doramectin (25-Cyclohexyl-5-O-demethyl-25-de (1-methylpropyl) avermectin A1A,. 25-Cylohexyl-avermectin B1, UK-67994, Dectomax) | Doramectin is a biosynthetic avermectin derived from a mutant of the original Streptomyces avermitilis strain supplemented with a cyclohexylcaboxylic acid starting unit. Doramectin was developed as an anthelmintic for internal parasite control. The presence of the cyclohexyl group replacing the sec-butyl moiety affords greater hydrophobicity and longer biological half-life compared to avermectin. Like the other milbemycin / avermectins, it selectively binds to parasite glutamate-gated chloride ion channels and disrupts neurotransmission leading to paralysis and death of the parasite. Group: Biochemicals. Alternative Names: 25-Cyclohexyl-5-O-demethyl-25-de (1-methylpropyl) avermectin A1A; 25-Cylohexyl-avermectin B1; UK-67994; Dectomax. Grades: Highly Purified. CAS No. 117704-25-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
